IFLScience on MSN3h
Inhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical TrialsA new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey towards seeing this treatment in the clinic. For this first phase, the aim ...
Laboratories use a variety of tests to analyze urine samples. These include pH measurement, specific gravity checks, and chemical composition analysis. High-end synthetic urine mimics all these ...
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...
After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder
The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...
The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first ...
A Salinas high school math teacher is on leave and under investigation after students accused him of trying to sell them ...
The agency started the review after finding a senior chemist manipulated data, impacting the accuracy of thousands of tests going back several years.
TSCA/FIFRA/TRI - EPA Releases Final Risk Evaluation For DINP, Finding Unreasonable Risk Of Injury To Human Health When Workers ...
From brutal drops to icy cold and muddy messes, this rugged tablet shrugs off the elements and keeps going strong.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback